Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

I think there’s a 72% probability that the FDA approves MNTA’s Copaxone ANDA before Teva’s patents expire in May 2014.

Considering that you thought there was a greater than 90% probability that the CERT would be granted and a 80% chance USSC takes the case doesn't bode well here.